First-in-human study demonstrates reduction of hard-to-reach ventricular tachycardias
Your access to the latest cardiovascular news, science, tools and resources.
Your access to the latest cardiovascular news, science, tools and resources.
Skip to main content #AHA24 Scientific Sessions call for abstracts! General submission open April 10 – June
ATLANTA — Obicetrapib, a novel cholesteryl ester transfer protein inhibitor, reduced atherogenic lipoprotein particles alone or in combination with ezetimibe, according to new data from…
Your access to the latest cardiovascular news, science, tools and resources.
This analysis shows that diabetic patients undergoing revascularization face substantially higher 5-year rates of all-cause mortality, myocardial infarction, repeat revascularizations, and stroke compared to non-diabetic…
Welcome to the official YouTube channel of the American Heart Association | American Stroke Association. We want to help you live healthier! Be sure to…
Tricuspid valve disease is an often underrecognized clinical problem that is associated with significant morbidity and mortality. Unfortunately, patients will often present late in their…
Among Hispanic women living in the U.S., 37% are affected by cardiovascular disease and it is the primary cause of death, according to a JACC…
Submit your abstracts, challenging cases, innovation, late-breaking trials and science.
Elevated blood pressure is a well-established risk factor for age-related cognitive decline. Long linked to cognitive impairment on vascular bases, increasing evidence suggests a potential…
Interventional cardiologists explored STS/ACR data from nearly 30,000 TAVR patients, presenting their findings in the Journal of the American Heart Association.